piracetam has been researched along with Central Nervous System Disease in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this analysis was to compare treatment-emergent adverse events (TEAE) related to use of levetiracetam (LEV) reported by young and elderly patients with anxiety and cognitive disorders, and young epilepsy patients." | 3.72 | Tolerability of levetiracetam in elderly patients with CNS disorders. ( Cramer, JA; Edrich, P; Krämer, G; Leppik, IE; Rue, KD, 2003) |
| "Levetiracetam is a Pregnancy Category C drug." | 2.41 | Safety profile of levetiracetam. ( Harden, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malykh, AG | 1 |
| Sadaie, MR | 1 |
| Cramer, JA | 1 |
| Leppik, IE | 1 |
| Rue, KD | 1 |
| Edrich, P | 1 |
| Krämer, G | 1 |
| Harden, C | 1 |
2 reviews available for piracetam and Central Nervous System Disease
| Article | Year |
|---|---|
Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
Topics: Animals; Anticonvulsants; Central Nervous System Diseases; Clinical Trials as Topic; Cognition Disor | 2010 |
Safety profile of levetiracetam.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Central Nervous System Diseases; Controlled Clinical T | 2001 |
1 other study available for piracetam and Central Nervous System Disease
| Article | Year |
|---|---|
Tolerability of levetiracetam in elderly patients with CNS disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anticonvulsants; Anxiety Disorders; Central Nervo | 2003 |